Embed Notice

From another network (non-public account so I can't link to it):
THIS IS HUGE! Researchers at Stanford University have developed a dual-antibody treatment that remains effective against ALL SARS-CoV-2 variants by targeting a less-mutable part of the virus. This breakthrough could lead to longer-lasting therapies that OUTPACE viral evolution.

Paper: https://www.science.org/doi/10.1126/scitranslmed.adq5720